MAPT and Alzheimer disease: Among the multiple modifications affecting aggregation propensity of the intrinsically disordered soluble protein tau and thereby contributing to the neurofibrillary pathology in AD and other tauopathies is abnormal truncation (Kovacech and Novak, 2010).